Moderna
MRNA
MRNA
138 hedge funds and large institutions have $2.1B invested in Moderna in 2019 Q2 according to their latest regulatory filings, with 57 funds opening new positions, 41 increasing their positions, 22 reducing their positions, and 21 closing their positions.
New
Increased
Maintained
Reduced
Closed
more first-time investments, than exits
New positions opened: | Existing positions closed:
more call options, than puts
Call options by funds: $ | Put options by funds: $
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more funds holding in top 10
Funds holding in top 10: →
30% more funds holding
Funds holding: 106 → 138 (+32)
1.51% more ownership
Funds ownership: 42.05% → 43.55% (+1.5%)
25% less capital invested
Capital invested by funds: $2.8B → $2.1B (-$704M)
Holders
138
Holding in Top 10
7
Calls
$16.7M
Puts
$8.1M
Top Buyers
| 1 | +$85.1M | |
| 2 | +$69.2M | |
| 3 | +$57.4M | |
| 4 |
TP
Theleme Partners
London,
United Kingdom
|
+$32.5M |
| 5 |
JPMorgan Chase & Co
New York
|
+$24M |
Top Sellers
| 1 | -$124M | |
| 2 | -$35.8M | |
| 3 | -$32.9M | |
| 4 |
RCM
RA Capital Management
Boston,
Massachusetts
|
-$30.8M |
| 5 |
HCM
Highline Capital Management
New York
|
-$18.9M |